Heart Decompensation, Acute Clinical Trial
Official title:
A Randomized, Double-Blind, Placebo-controlled, Single Continuous Intravenous Infusion Study of BMS-986231 to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Healthy Japanese and Non- Asian Participants
The purpose of this Phase 1 study is to evaluate the safety, tolerability, PK, and pharmacodynamics (PD) of BMS-986231 in healthy Japanese and Non-Asian participants. There is no formal hypothesis to be statistically tested.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03210909 -
Pharmacokinetics and Metabolism of [14C] BMS-986231 in Healthy Male Participants
|
Phase 1 |